This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other congenital malformations of eye
Q17_OTHER_CONGEN_MALFO_EYE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
48 |
4. Check minimum number of eventsNone |
48 |
5. Include endpoints |
48 |
6. Filter based on genotype QC (FinnGen only) |
48 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Aliae malformationes congenitae oculi
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of eye
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 525 | 234 | 288 |
| Only index persons | 427 | 193 | 234 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 18.66 | 28.71 | 9.93 |
| Only index persons | 23.10 | 30.94 | 16.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 48 | 26 | 22 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 43.98 | 42.45 | 45.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
13
54
2.93
2.45
1.9
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
43
341
3.50
2.23
17.8
20.6
%
13.6
13.6
0.03
43
334
(3044889) 12 lead EKG panel
34
237
2.49
2.14
3.7
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
116
2.24
1.87
4.4
6.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
48
431
+∞
1.81
21.4
23.2
g/l
131.3
132.7
0.28
48
422
(3010813) Leukocytes [#/volume] in Blood
48
431
+∞
1.81
21.5
23.2
e9/l
6.6
6.9
0.27
48
415
(3007461) Platelets [#/volume] in Blood
48
431
+∞
1.81
21.4
23.1
e9/l
244.7
253.1
0.38
48
418
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
79
2.31
1.73
3.3
2.8
e6/l
0.1
0.9
—
9
48
(3018418) pH of Serum or Plasma
17
97
2.17
1.62
7.8
3.1
ph
7.4
7.4
—
5
22
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
150
2.02
1.54
5.4
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
124
2.05
1.53
5.4
3.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
76
2.19
1.49
3.4
3.1
e6/l
7.1
2.3
—
8
45
(3018095) Leukocytes [#/volume] in Urine
23
152
1.99
1.47
6.1
4.0
e6/l
9.7
75.4
1.72
18
107
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
39
324
2.08
1.29
13.2
13.2
ml/min/173m2
83.4
83.8
0.03
32
251
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
37
2.39
1.29
2.8
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
43
373
2.46
1.20
16.2
17.5
%
36.8
39.1
0.73
36
285
(40768804) Tissue Pathology biopsy report
19
127
1.82
1.11
1.7
2.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
24
173
1.77
1.10
8.4
10.9
mmol/l
1.2
1.2
0.64
24
165
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
128
1.80
1.08
4.9
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
129
1.78
1.05
2.0
1.8
pmol/l
77.2
91.3
—
10
63
(3042936) Bacteria identified in Isolate by Culture
11
63
1.97
1.00
2.0
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
96
1.82
0.99
3.9
3.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
17
115
1.74
0.94
2.7
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
43
384
2.15
0.90
16.4
18.6
mmol/l
139.6
139.5
0.08
43
374
(42870588) Differential panel, method unspecified - Blood
21
153
1.66
0.88
5.6
8.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
13
83
1.78
0.86
2.8
2.0
mmol/l
1.2
1.3
0.25
13
69
(3019225) pH of Specimen
0
24
0.00
0.82
0.0
8.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
24
0.00
0.82
0.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
34
284
1.68
0.81
6.5
7.4
u/l
91.1
93.7
0.08
34
271
(3023368) Bacteria identified in Blood by Culture
17
120
1.65
0.79
3.0
5.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
7
38
1.98
0.78
1.0
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
43
386
2.09
0.76
16.7
18.5
mmol/l
4.0
4.0
0.04
43
374
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
29
1.81
0.65
1.2
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
5
85
0.54
0.63
1.4
4.6
umol/l
346.2
346.6
—
5
70
(3003694) ABO and Rh group [Type] in Blood
14
99
1.58
0.63
1.6
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
21
0.00
0.61
0.0
1.9
—
—
—
0
0
(3013512) EKG study
13
91
1.59
0.61
1.5
5.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
9
59
1.64
0.59
1.8
1.8
nmol/l
1397.2
1207.8
—
9
49
(3002256) Pathology report gross observation
6
37
1.71
0.58
1.0
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
30
255
1.47
0.56
5.5
4.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
112
0.66
0.43
3.6
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
20
167
1.34
0.37
3.3
2.8
ug/l
129.4
88.5
0.40
20
159
(3015736) pH of Urine
18
148
1.35
0.36
4.4
3.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
44
1.41
0.36
1.2
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
46
1.35
0.34
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
53
1.37
0.33
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
54
1.35
0.32
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
12
94
1.37
0.32
3.6
4.8
ug/l
1.2
2.2
0.75
12
79
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
7
55
1.32
0.31
4.1
2.3
%
24.7
25.7
—
7
50
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
55
1.32
0.31
1.3
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
55
1.32
0.31
1.3
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
37
342
1.36
0.31
4.3
4.4
mu/l
1.7
2.0
0.91
37
308
(3006504) Eosinophils/100 leukocytes in Blood
23
201
1.28
0.29
6.2
8.0
%
4.1
3.0
1.43
23
187
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
35
323
1.31
0.28
4.5
4.1
mmol/l
1.4
1.4
0.28
35
288
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
72
1.31
0.28
2.2
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
23
202
1.27
0.27
6.2
8.1
%
9.2
8.5
0.55
23
191
(3018010) Neutrophils/100 leukocytes in Blood
23
202
1.27
0.27
7.3
7.8
%
52.6
53.3
0.07
23
192
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
74
1.27
0.27
1.2
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
15
125
1.29
0.27
4.1
3.3
mmol/l
2.4
2.4
0.77
15
110
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
37
1.39
0.24
1.4
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
5
42
1.21
0.22
4.4
10.7
mmol/l
1.1
1.4
—
5
37
(3002030) Lymphocytes/100 leukocytes in Blood
23
206
1.22
0.22
6.2
8.0
%
29.5
31.0
0.16
23
193
(3044290) Cell count panel - Cerebral spinal fluid
0
11
0.00
0.21
0.0
5.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
3.4
—
3.8
—
0
11
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
47
1.32
0.21
2.2
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
0.3
—
0
13
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
3.5
—
3.7
—
0
13
(40760892) CBC W Ordered Manual Differential panel - Blood
10
81
1.30
0.21
6.3
6.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
3.4
—
282.1
—
0
14
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.1
—
0
14
(3022096) Basophils/100 leukocytes in Blood
22
198
1.21
0.19
6.5
8.0
%
0.8
0.7
0.82
22
187
(3044640) Blood type and Crossmatch panel - Blood
14
120
1.24
0.19
1.9
3.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
60
1.19
0.19
2.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
11
92
1.25
0.18
1.8
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
70
1.17
0.17
2.3
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
9
78
1.19
0.17
1.4
1.4
nmol/l
31.0
21.9
—
9
63
(3032080) INR in Blood by Coagulation assay
16
142
1.19
0.15
9.9
7.8
inr
1.2
1.2
—
8
45
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
104
0.83
0.15
1.7
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
21
192
1.17
0.14
5.4
8.3
umol/l
23.5
19.6
0.12
21
183
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
35
333
1.19
0.14
5.1
4.6
mmol/l
2.6
2.7
0.25
35
300
(3041096) Erythrocytes [Presence] in Urine by Automated
11
95
1.20
0.13
5.9
3.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
34
325
1.16
0.11
4.7
4.3
mmol/l
5.7
5.8
0.59
34
294
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
30
314
0.88
0.09
5.1
5.5
mmol/mol
37.3
39.3
0.98
30
289
(3048689) Calprotectin [Mass/mass] in Stool
5
59
0.83
0.09
1.0
2.0
ug/g
97.8
125.6
—
5
45
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6
73
0.80
0.08
1.7
1.7
pmol/l
469.0
530.3
—
6
64
(3003458) Phosphate [Moles/volume] in Serum or Plasma
8
76
1.06
0.08
11.3
9.1
mmol/l
1.1
1.2
—
8
70
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
27
281
0.91
0.06
3.0
3.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
16
169
0.92
0.04
6.4
5.2
g/l
36.5
35.7
0.17
16
160
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
15
142
1.08
0.03
2.9
3.6
ng/l
32.9
44.1
—
9
102
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
32
315
1.05
0.00
3.7
3.8
mmol/l
1.1
1.2
0.25
32
280
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
10
104
0.95
0.00
3.7
3.1
u/l
71.2
55.3
—
10
97
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
28
284
0.97
0.00
4.2
3.9
pmol/l
14.8
14.7
0.06
28
262
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
16
162
0.98
0.00
4.6
5.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
3.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
1.5
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
139.8
—
0
6
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
6.8
—
78.2
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
58
1.04
0.00
8.5
16.5
mmol/l
25.2
24.7
—
6
58
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
166.3
—
0
9
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.6
—
1685.5
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1739.2
—
0
6
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
5
53
0.94
0.00
1.4
5.3
%
1.6
1.6
—
5
48
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
1.4
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
72.7
—
0
9
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
54
0.92
0.00
7.2
11.1
mmol/l
102.4
104.4
—
5
54
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.2
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.9
—
6.4
—
0
7
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
148.4
—
0
5
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
0.4
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7
69
1.02
0.00
5.4
10.0
mmol/l
0.7
0.8
—
7
64
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
49
1.02
0.00
1.4
2.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
88.7
—
0
6
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
4.1
—
13.2
—
0
7
(3000991) Gas panel - Venous blood
5
58
0.85
0.00
7.0
8.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
1.5
—
0
5
(4094501)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
11.5
—
0
6
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.6
—
3.0
—
0
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_EYE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_EYE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_EYE – Other congenital malformations of eye
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data